SERG Technologies, a London, UK-based developer of a device that provides early diagnosis and monitoring of Parkinson’s disease, raised £1.6m in funding.
Backers included Mercia, Velocity Partners, Newable, the Imperial College Innovation Fund, a Japanese corporation and private investors.
The company intends to use the funds to achieve regulatory approval to launch the system in the UK and US, and work on a potential treatment.
Founded in 2019 by Dr Ravi Vaidyanathan and Dr Sam Wilson and led by Dr Christos Kapatos, CEO, based on their research at Imperial College, London, Serg has developed a technology platform, which uses acoustic sensors to detect movement and assess the state of the patient’s muscles, provides a more objective way to identify the symptoms and measure the severity.
Its NuRO platform could not only provide early diagnosis, but also be used for continuous monitoring of patients to help doctors to manage their disease more effectively. There is also potential to use the devices to deliver electrical stimulation of the patient’s muscles to help relieve the symptoms.
FinSMEs
12/07/2022